Global Checkpoint Inhibitors for Treating Cancer Market Survey and Trend Research 2018
Summary
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Checkpoint Inhibitors for Treating Cancer Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Bristol-Myers Squibb(BMS) (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Merck (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Roche (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Checkpoint Inhibitors for Treating Cancer Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Bristol-Myers Squibb(BMS) (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Merck (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Roche (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Checkpoint Inhibitors for Treating Cancer Market 2012-2017, by Type, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2018-2023, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2018-2023, by Type, in Volume
Table Bristol-Myers Squibb(BMS) Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Companies, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2012-2017, by Companies, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Companies in 2017, in Volume
Table Checkpoint Inhibitors for Treating Cancer Demand 2012-2017, by Application, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Demand 2012-2017, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2018-2023, by Application, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2018-2023, by Application, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market 2012-2017, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2012-2017, by Region, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2018-2023, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2018-2023, by Region, in Volume
Table GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Checkpoint Inhibitors for Treating Cancer Market 2012-2017, by Type, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2018-2023, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2018-2023, by Type, in Volume
Table Bristol-Myers Squibb(BMS) Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Companies, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2012-2017, by Companies, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Companies in 2017, in Volume
Table Checkpoint Inhibitors for Treating Cancer Demand 2012-2017, by Application, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Demand 2012-2017, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2018-2023, by Application, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2018-2023, by Application, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market 2012-2017, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2012-2017, by Region, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2018-2023, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Checkpoint Inhibitors for Treating Cancer Industry Chain Structure
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2012-2017, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2012-2017, by Type, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Checkpoint Inhibitors for Treating Cancer Industry Chain Structure
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2012-2017, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2012-2017, by Type, in Volume
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
